Chronic obstructive pulmonary disease (COPD) is a critical global health concern affecting an increasing proportion of people living in high, middle, and low-income countries. COPD is a progressive respiratory disorder characterized by partially reversible airway obstruction and lung hyperinflation conditions that present alongside systemic manifestations ([@b14-copd-3-393]; [@b41-copd-3-393]; [@b4-copd-3-393]; [@b1-copd-3-393]; [@b32-copd-3-393];Taticioglu 2007; [@b42-copd-3-393]). It has been suggested that by the year 2020, COPD will surpass cancer and cardiac disease to become the third leading cause of death worldwide ([@b19-copd-3-393]). The emerging global importance of COPD, and the complex implication of such increasing prevalence rates at the micro- (ie, client), meso- (ie, institution), and macro (ie, country) levels, has been highlighted by others such as [@b5-copd-3-393], [@b38-copd-3-393], and [@b7-copd-3-393]. Overall, the evidence seems to suggest that variables such as an ageing population, high rates of tobacco use, and limited access to health services are key drivers of the global prevalence of COPD. Moreover, as suggested by others, COPD and related pulmonary diseases may become important in low-income countries where prevalence rates are rapidly increasing and where the overall burden is the greatest ([@b6-copd-3-393]; [@b12-copd-3-393], [@b13-copd-3-393]; [@b1-copd-3-393]).

The neoclassical economic viewpoint posits that demand (the amount of services that are deemed medically necessary) and supply (the amount of financial or human resources available) are in 'equilibrium' when demand is fully aligned with available supply ([@b21-copd-3-393]; [@b15-copd-3-393]). Alternatively, the so-called 'market' is deemed to be in a state of disequilibrium when demand is higher (or at times lower) than supply. A proxy measure that has been established to measure the extent to which a health care market is in alignment is wait time. In other words, short wait times signal some degree of alignment, and long wait times indicates disequilibrium between demand and supply ([@b30-copd-3-393], [@b29-copd-3-393]). Health care is infinitely complex, and does not necessarily follow such predictable and established dynamics; nonetheless, applying a neoclassical understanding of market composition within context of COPD can be instructive in establishing the degree to which demand and supply are aligned. The literature seems to indicate that, from a macro-level perspective, demand for health services for COPD has risen sharply, that the health care supply chain infrastructure (or supply) has not kept pace, and that without addressing this disequilibrium a crisis in access to services for COPD will ensue ([@b37-copd-3-393]; [@b11-copd-3-393]; [@b33-copd-3-393]; [@b39-copd-3-393]; [@b40-copd-3-393]; [@b16-copd-3-393]; [@b24-copd-3-393]).

Demand for health services are 'insatiable,' and that increasing financial and human resources can address short-term demand, which in turn engender increase in public expectation and over-utilization of such services. Financial allocation for health services tends to occur in an environment of economic scarcity in all settings; in other words, there are rarely sufficient resources to allocate across all conditions and settings. This complex economic reality makes increasing supply somewhat less sustainable and possibly irrelevant in some resource-poor countries. Alternatively, strategies that reduce demand can create some degree of alignment between existing supply and demand, and is arguably more promising than adding more financial resource to meet demand. For instance, we have reported elsewhere that the application rehabilitation services for individuals living with COPD and other conditions has the potential to act as a mediating factor to modulate long term health service demand of more costly and resource-intensive health services ([@b29-copd-3-393]). Although further empirical evidence is required, there is a growing knowledge base that indicates that the introduction of rehabilitation early and throughout a disease process can yield positive clinical and social outcomes ([@b10-copd-3-393]; [@b31-copd-3-393]; [@b35-copd-3-393]).

Pulmonary rehabilitation (PR) is a multidisciplinary program that integrates components of exercise training, education, nutritional therapy, psychological support, and promotes self-management ([@b2-copd-3-393]; [@b34-copd-3-393]; [@b17-copd-3-393]). There are numerous benefits of PR, including: improved health-related quality of life, improved exercise capacity, decreased perception of dyspnea, reduced admissions and days in hospital, and reduced anxiety and depression ([@b27-copd-3-393]; [@b17-copd-3-393]). PR therefore offers the potential to improve clinical outcomes and reduce aggregated direct and indirect costs associated with COPD ([@b18-copd-3-393]; [@b22-copd-3-393]). Although the introduction of PR programs require some degree of up-front financial and human resource investments; it can also be argued that the long-term cost savings that may be realized by offsetting the demand for more expensive services. Despite this argument, there is disequilibrium between demand and supply of PR services for people living with COPD. According to the Canadian Institutes for Health Information, only 2.8% of Canadians who would benefit from PR programs receive these services, and that on average clients with pulmonary conditions have a wait time of 6 days for inpatient rehabilitation services ([@b9-copd-3-393]). Similarly, results from a 1998 survey of PR programs across North America, Europe, and Japan indicated that programs were available at only 56% of hospitals ([@b25-copd-3-393]). Overall, it appears that rehabilitation programs and services for pulmonary conditions are only available for a small percentage of the client population ([@b8-copd-3-393], [@b7-copd-3-393]). Despite the relatively low uptake, PR programs provided within the community and home setting have been demonstrated to be cost-effective, improve quality of life, and decrease the number of future hospital days for the patient ([@b23-copd-3-393]; [@b14-copd-3-393]). In addition to poor availability of PR services, [@b14-copd-3-393] reported that primary care physicians under-diagnose COPD, and that despite having symptoms of dyspnea, clients in general are not being treated for early symptoms related to COPD. [@b14-copd-3-393] also suggested that health care costs for COPD could be better controlled with early detection and prevention within the primary care setting, and that PR would reduce the demand on emergency rooms and acute care settings.

The important global public policy issue is that demand for health and rehabilitation services associated with COPD appears to be outstripping supply. The evidence seems to suggest that PR services has the potential to mediate demand for more resource-intense services such as those provided during an acute exacerbation necessitating an emergency visit or hospital admission. As noted by [@b3-copd-3-393], [@b26-copd-3-393], [@b20-copd-3-393], and [@b32-copd-3-393], early intervention and PR program improve client and system-wide outcomes. Although the argument to include PR services as part of a comprehensive program has an evidence-based rationale, this reality does not easily translate into a decision-making or policy-making framework. We have argued elsewhere that the use of evidence at the policy level is infinitely more complex, and that evidence must be interpreted within context of prevailing values and other political pressures ([@b28-copd-3-393]). Based on rapidly increasing rates of COPD, we signal the need to reflect health reform strategies, such as integrating rehabilitation, health promotion and prevention, as cost-effective approaches to mediate demand for growing demand for health services related COPD in a global environment of economic scarcity. Although implementing PR programs requires some degree of initial investment, it has the potential to yield important social and aggregated financial costs savings in a health arena of global consequence.
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